Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model (Q28748851)

7

object named as

Maarten J Postma

0 references

author name string

Robin de Vries

1

0 references

Joop F P Schellekens

3

0 references

Florens G A Versteegh

4

0 references

Tjalke A Westra

5

0 references

John J Roord

Creative Commons Attribution 4.0 International

6

0 references

language of work or name

English

0 references

publication date

15 October 2010

0 references

published in

PLOS One

0 references

volume

5

0 references

issue

10

0 references

page(s)

e13392

0 references

copyright license

start time

15 October 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Acellular vaccines for preventing whooping cough in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Health-state valuations for pertussis: methods for valuing short-term health states

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Herd immunity: history, theory, practice

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Cost-effectiveness of adult pertussis vaccination in Germany

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Emerging methods in economic modeling of imaging costs and outcomes a short report on discrete event simulation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed (Boostrix) US formulation): use as a single-dose booster immunization in adolescents aged 10-18 years.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Acellular pertussis vaccine safety and efficacy in children, adolescents and adults

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Analysis of Bordetella pertussis populations in European countries with different vaccination policies

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents: implications for the United States

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Duration of immunity against pertussis after natural infection or vaccination

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Health burden of pertussis in adolescents and adults

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Pertussis sources of infection and routes of transmission in the vaccination era.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Epidemiology of pertussis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Economic evaluation of an extended acellular pertussis vaccine program for adolescents in Québec, Canada

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Societal costs and morbidity of pertussis in adolescents and adults.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Adolescent and adult pertussis vaccination: computer simulations of five new strategies

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Systematic review of the effects of pertussis vaccines in children.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Deaths from pertussis are underestimated in England

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccination

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

The friction cost method for measuring indirect costs of disease.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

An age-structured model for pertussis transmission

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

The estimation of age-related rates of infection from case notifications and serological data

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Pertussis and pertussis vaccine: further analysis of benefits, risks and costs.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

The measurement and interpretation of age-specific vaccine efficacy

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Pertussis Vaccine — An Analysis of Benefits, Risks and Costs

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955521

Morbidity of pertussis in adolescents and adults

3 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Pharmacoeconomic analyses using discrete event simulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Efficacy of an acellular pertussis vaccine among adolescents and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Cost effectiveness of pertussis vaccination in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Pertussis vaccination strategies for neonates--an exploratory cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

An economic evaluation of universal pertussis vaccination in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

A model based evaluation of the 1996-7 pertussis epidemic in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Simulations of pertussis epidemiology in the United States: effects of adult booster vaccinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Using computer simulations to compare pertussis vaccination strategies in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Prospective Multinational Study of Pertussis Infection in Hospitalized Infants and Their Household Contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Pertussis Immunization of Adolescents in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013392

Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs

21 January 2018

1 reference

12 December 2020

Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997

1 reference

12 December 2020

Economic evaluation of a new acellular vaccine for pertussis in Canada

1 reference

12 December 2020

Pertussis in adolescents and adults: should we vaccinate?

1 reference

12 December 2020

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

1 reference

12 December 2020

The incidence of pertussis in the Netherlands has remained high since an outbreak occurred in 1996

1 reference

12 December 2020

Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents

1 reference

12 December 2020

Economic evaluation of vaccination programs: the impact of herd-immunity

1 reference

12 December 2020

Laboratory-confirmed reinfections with Bordetella pertussis

1 reference

12 December 2020

Estimating the potential health gain and cost consequences of introducing a pre-school DTPa pertussis booster into the UK child vaccination schedule

1 reference

12 December 2020

Costs of illness due to Bordetella pertussis in families

1 reference

12 December 2020

Underreporting of pertussis deaths in the United States: need for improved surveillance

1 reference

12 December 2020

Using pharmacoeconomics for policy making: is rational decision making enhanced by applying thresholds for cost-effectiveness?

1 reference

12 December 2020